封面
市場調查報告書
商品編碼
1746514

日本醫藥過濾市場報告(按產品、技術、應用、營運規模和地區)2025-2033

Japan Pharmaceutical Filtration Market Report by Product, Technique, Application, Scale of Operation, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 122 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2024年,日本醫藥過濾市場規模達8.123億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到23.826億美元,2025-2033年期間的複合年成長率(CAGR)為12.07%。政府機構為確保藥品生產純度而實施的嚴格監管是推動市場成長的主要動力。

藥物過濾是指透過各種過濾技術從醫療產品或其生產環境中去除不需要的顆粒或污染物。其主要目的是去除微生物、顆粒物、內毒素和其他可能損害藥品完整性和純度的物質等雜質。該工藝在確保藥品的安全性、品質和功效方面發揮關鍵作用。它應用於整個藥品生產過程的多個階段,包括原料的淨化、中間產品的加工以及最終產品的過濾。過濾方法的選擇取決於製藥業的特定要求。

日本製藥濾波市場趨勢:

受生物製藥產業蓬勃發展的推動,日本醫藥過濾市場正經歷大幅成長。同時,慢性病在人群中的日益普及也促進了市場擴張。此外,對腸外給藥、注射和無菌製程的需求不斷成長,凸顯了對可靠無菌過濾解決方案的需求,從而推動了製藥業對高性能過濾器和過濾介質的需求,這也是另一個重要的成長促進因素。此外,過濾技術的持續進步,以改進的過濾器設計、創新的過濾介質和先進的薄膜技術為特徵,正在促進尖端過濾解決方案的採用。這些進步帶來了顯著的優勢,包括縮短處理時間、提高產品產量和增強成本效益。此外,由於一次性技術具有降低交叉污染風險、簡化驗證流程和提高營運效率等相關優勢,人們對一次性技術的日益重視也成為市場成長的催化劑。此外,包括治療性蛋白質、單株抗體和疫苗在內的創新療法日益普及,也促使生物技術和生物製藥公司對過濾系統的使用率不斷提高。這些因素的共同作用,將使日本製藥過濾市場在未來幾年引領醫療保健和生物製藥領域的發展。

日本製藥過濾市場細分:

產品洞察:

  • 薄膜過濾器
    • MCE薄膜過濾器
    • 塗層醋酸纖維素膜過濾器
    • PTFE膜過濾器
    • 尼龍薄膜過濾器
    • PVDF薄膜過濾器
    • 其他
  • 預過濾器和深度介質
    • 玻璃纖維過濾器
    • PTFE纖維過濾器
  • 免洗系統
  • 墨盒和膠囊
  • 濾光片支架
  • 過濾配件
  • 其他

技術見解:

  • 微濾
  • 超濾
  • 錯流過濾
  • 納濾
  • 其他

應用程式洞察:

  • 最終產品加工
    • 活性藥物成分過濾
    • 無菌過濾
    • 蛋白質純化
    • 疫苗和抗體加工
    • 配方和填充解決方案
    • 病毒清除
  • 原料過濾
    • 媒體緩衝區
    • 預過濾
    • 生物負載測試
  • 細胞分離
  • 水淨化
  • 空氣淨化

營運規模洞察:

  • 生產規模
  • 中試規模
  • 研發規模

競爭格局:

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外,報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題:

  • 日本醫藥過濾市場迄今表現如何?未來幾年將如何表現?
  • COVID-19 對日本醫藥過濾市場有何影響?
  • 日本醫藥過濾市場依產品分類是怎樣的?
  • 日本醫藥過濾市場依技術分類的分佈如何?
  • 日本醫藥過濾市場依應用分為哪些類型?
  • 日本醫藥過濾市場依經營規模分類是怎樣的?
  • 日本醫藥過濾市場的價值鏈分為哪些階段?
  • 日本醫藥過濾的關鍵促進因素和挑戰是什麼?
  • 日本醫藥過濾市場的結構是怎麼樣的?主要參與者是誰?
  • 日本醫藥過濾市場的競爭程度如何?

本報告回答的關鍵問題:

  • 日本醫藥過濾市場迄今表現如何?未來幾年將如何表現?
  • COVID-19 對日本醫藥過濾市場有何影響?
  • 日本醫藥過濾市場依產品分類是怎樣的?
  • 日本醫藥過濾市場依技術分類的分佈如何?
  • 日本醫藥過濾市場依應用分為哪些類型?
  • 日本醫藥過濾市場依經營規模分類是怎樣的?
  • 日本醫藥過濾市場的價值鏈分為哪些階段?
  • 日本醫藥過濾的關鍵促進因素和挑戰是什麼?
  • 日本醫藥過濾市場的結構是怎麼樣的?主要參與者是誰?
  • 日本醫藥過濾市場的競爭程度如何?

目錄

第1章:前言

第2章:範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章:執行摘要

第4章:日本製藥過濾市場-簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭情報

第5章:日本製藥過濾市場概況

  • 歷史與當前市場趨勢(2019-2024)
  • 市場預測(2025-2033)

第6章:日本醫藥過濾市場-細分:依產品

  • 薄膜過濾器
    • 概述
    • 市場區隔
      • MCE薄膜過濾器
      • 塗層醋酸纖維素膜過濾器
      • PTFE膜過濾器
      • 尼龍薄膜過濾器
      • PVDF薄膜過濾器
      • 其他
  • 預過濾器和深度介質
    • 概述
    • 市場區隔
      • 玻璃纖維過濾器
      • PTFE纖維過濾器
  • 免洗系統
    • 概述
  • 墨盒和膠囊
    • 概述
  • 濾光片支架
    • 概述
  • 過濾配件
    • 概述
  • 其他

第7章:日本醫藥過濾市場-細分:依技術

  • 微濾
    • 概述
  • 超濾
    • 概述
  • 錯流過濾
    • 概述
  • 納濾
    • 概述
  • 其他

第 8 章:日本醫藥過濾市場 - 細分:按應用

  • 最終產品加工
    • 概述
    • 市場區隔
      • 活性藥物成分過濾
      • 無菌過濾
      • 蛋白質純化
      • 疫苗和抗體加工
      • 配方和填充解決方案
      • 病毒清除
  • 原料過濾
    • 概述
    • 市場區隔
      • 媒體緩衝區
      • 預過濾
      • 生物負載測試
  • 細胞分離
    • 概述
  • 水淨化
    • 概述
  • 空氣淨化
    • 概述

第9章:日本醫藥過濾市場-細分:依經營規模

  • 生產規模
    • 概述
  • 中試規模
    • 概述
  • 研發規模
    • 概述

第 10 章:日本製藥過濾市場 - 競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳獲勝策略
  • 競爭儀錶板
  • 公司評估象限

第 11 章:關鍵參與者簡介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 12 章:日本製藥過濾市場-產業分析

  • 促進因素、限制因素和機遇
    • 概述
    • 驅動程式
    • 限制
    • 機會
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 價值鏈分析

第 13 章:附錄

簡介目錄
Product Code: SR112025A19970

Japan pharmaceutical filtration market size reached USD 812.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,382.6 Million by 2033, exhibiting a growth rate (CAGR) of 12.07% during 2025-2033. The implementation of stringent regulations by government bodies to ensure purity in the production of pharmaceuticals products is primarily driving the market growth.

Pharmaceutical filtration involves the elimination of undesired particles or contaminants from medical products or their production environments through diverse filtration techniques. The primary aim is to eradicate impurities like microorganisms, particulate matter, endotoxins, and other substances that could jeopardize the pharmaceuticals' integrity and purity. This process holds a pivotal role in guaranteeing the safety, quality, and efficacy of pharmaceutical products. It is applied at multiple stages throughout the drug manufacturing process, encompassing the purification of raw materials, processing of intermediate products, and the final filtration of the end product. The choice of filtration methods varies based on the specific requirements of the pharmaceuticals industry.

Japan Pharmaceutical Filtration Market Trends:

The Japan pharmaceutical filtration market is experiencing substantial growth, propelled by a significant upsurge in the biopharmaceutical industry. Concurrently, the escalating prevalence of chronic diseases among the population is contributing to market expansion. Besides this, the increasing demand for parenteral drugs, injectable formulations, and aseptic processing underscores the need for reliable sterile filtration solutions, thereby driving the demand for high-performance filters and filter media within the pharmaceuticals sector, which is acting as another significant growth-inducing factor. Moreover, ongoing technological advancements in filtration, characterized by improved filter designs, innovative filter media, and advanced membrane technologies, are fostering the adoption of cutting-edge filtration solutions. These advancements offer notable advantages, including reduced processing time, improved product yield, and enhanced cost-effectiveness. Furthermore, the growing emphasis on single-use technologies is a catalyst for market growth, given the associated benefits such as reduced cross-contamination risks, simplified validation processes, and improved operational efficiency. Additionally, the increased adoption of innovative treatment therapies, including therapeutic proteins, monoclonal antibodies, and vaccines, has led to heightened utilization of filtration systems by biotechnology and biopharmaceutical companies. The confluence of these factors will position the Japan pharmaceutical filtration market at the forefront of advancements in the healthcare and biopharmaceutical sectors in the coming years.

Japan Pharmaceutical Filtration Market Segmentation:

Product Insights:

  • Membrane Filters
    • MCE Membrane Filters
    • Coated Cellulose Acetate Membrane Filters
    • PTFE Membrane Filters
    • Nylon Membrane Filters
    • PVDF Membrane Filters
    • Others
  • Prefilters and Depth Media
    • Glass Fiber Filters
    • PTFE Fiber Filters
  • Single-use Systems
  • Cartridges and Capsules
  • Filter Holders
  • Filtration Accessories
  • Others

Technique Insights:

  • Microfiltration
  • Ultrafiltration
  • Crossflow Filtration
  • Nanofiltration
  • Others

Application Insights:

  • Final Product Processing
    • Active Pharmaceutical Ingredient Filtration
    • Sterile Filtration
    • Protein Purification
    • Vaccines and Antibody Processing
    • Formulation and Filling Solutions
    • Viral Clearance
  • Raw Material Filtration
    • Media Buffer
    • Pre-Filtration
    • Bioburden Testing
  • Cell Separation
  • Water Purification
  • Air Purification

Scale of Operation Insights:

  • Manufacturing Scale
  • Pilot-scale
  • Research and Development Scale

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan pharmaceutical filtration market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan pharmaceutical filtration market?
  • What is the breakup of the Japan pharmaceutical filtration market on the basis of product?
  • What is the breakup of the Japan pharmaceutical filtration market on the basis of technique?
  • What is the breakup of the Japan pharmaceutical filtration market on the basis of application?
  • What is the breakup of the Japan pharmaceutical filtration market on the basis of scale of operation?
  • What are the various stages in the value chain of the Japan pharmaceutical filtration market?
  • What are the key driving factors and challenges in the Japan pharmaceutical filtration?
  • What is the structure of the Japan pharmaceutical filtration market and who are the key players?
  • What is the degree of competition in the Japan pharmaceutical filtration market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pharmaceutical Filtration Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Pharmaceutical Filtration Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Pharmaceutical Filtration Market - Breakup by Product

  • 6.1 Membrane Filters
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 MCE Membrane Filters
      • 6.1.3.2 Coated Cellulose Acetate Membrane Filters
      • 6.1.3.3 PTFE Membrane Filters
      • 6.1.3.4 Nylon Membrane Filters
      • 6.1.3.5 PVDF Membrane Filters
      • 6.1.3.6 Others
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 Prefilters and Depth Media
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Glass Fiber Filters
      • 6.2.3.2 PTFE Fiber Filters
    • 6.2.4 Market Forecast (2025-2033)
  • 6.3 Single-use Systems
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Cartridges and Capsules
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Filter Holders
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)
  • 6.6 Filtration Accessories
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2019-2024)
    • 6.6.3 Market Forecast (2025-2033)
  • 6.7 Others
    • 6.7.1 Historical and Current Market Trends (2019-2024)
    • 6.7.2 Market Forecast (2025-2033)

7 Japan Pharmaceutical Filtration Market - Breakup by Technique

  • 7.1 Microfiltration
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Ultrafiltration
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Crossflow Filtration
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Nanofiltration
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2019-2024)
    • 7.5.2 Market Forecast (2025-2033)

8 Japan Pharmaceutical Filtration Market - Breakup by Application

  • 8.1 Final Product Processing
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Segmentation
      • 8.1.3.1 Active Pharmaceutical Ingredient Filtration
      • 8.1.3.2 Sterile Filtration
      • 8.1.3.3 Protein Purification
      • 8.1.3.4 Vaccines and Antibody Processing
      • 8.1.3.5 Formulation and Filling Solutions
      • 8.1.3.6 Viral Clearance
    • 8.1.4 Market Forecast (2025-2033)
  • 8.2 Raw Material Filtration
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Segmentation
      • 8.2.3.1 Media Buffer
      • 8.2.3.2 Pre-Filtration
      • 8.2.3.3 Bioburden Testing
    • 8.2.4 Market Forecast (2025-2033)
  • 8.3 Cell Separation
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Water Purification
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)
  • 8.5 Air Purification
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2019-2024)
    • 8.5.3 Market Forecast (2025-2033)

9 Japan Pharmaceutical Filtration Market - Breakup by Scale of Operation

  • 9.1 Manufacturing Scale
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Pilot-scale
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Research and Development Scale
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)

10 Japan Pharmaceutical Filtration Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Pharmaceutical Filtration Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix